Copyright Reports & Markets. All rights reserved.

Global Transdermal Patch Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Transdermal Patch Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Methyl Salicylate-based Patch
    • 1.3.3 Rivastigmine Transdermal Patch
    • 1.3.4 Fentanyl Transdermal Patch
    • 1.3.5 Lidocaine Patch
    • 1.3.6 Diclofenac Patch
    • 1.3.7 Nicotine Transdermal Patch
    • 1.3.8 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Transdermal Patch Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Rx Channel
    • 1.4.3 OTC Channel
  • 1.5 Global Transdermal Patch Market Size & Forecast
    • 1.5.1 Global Transdermal Patch Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Transdermal Patch Sales Quantity (2020-2031)
    • 1.5.3 Global Transdermal Patch Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Hisamitsu Pharmaceutical
    • 2.1.1 Hisamitsu Pharmaceutical Details
    • 2.1.2 Hisamitsu Pharmaceutical Major Business
    • 2.1.3 Hisamitsu Pharmaceutical Transdermal Patch Product and Services
    • 2.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Transdermal Patch Product and Services
    • 2.2.4 Johnson & Johnson Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Johnson & Johnson Recent Developments/Updates
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Transdermal Patch Product and Services
    • 2.3.4 Novartis Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Novartis Recent Developments/Updates
  • 2.4 UCB Pharma
    • 2.4.1 UCB Pharma Details
    • 2.4.2 UCB Pharma Major Business
    • 2.4.3 UCB Pharma Transdermal Patch Product and Services
    • 2.4.4 UCB Pharma Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 UCB Pharma Recent Developments/Updates
  • 2.5 Mylan
    • 2.5.1 Mylan Details
    • 2.5.2 Mylan Major Business
    • 2.5.3 Mylan Transdermal Patch Product and Services
    • 2.5.4 Mylan Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Mylan Recent Developments/Updates
  • 2.6 Teva Pharmaceutical
    • 2.6.1 Teva Pharmaceutical Details
    • 2.6.2 Teva Pharmaceutical Major Business
    • 2.6.3 Teva Pharmaceutical Transdermal Patch Product and Services
    • 2.6.4 Teva Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Teva Pharmaceutical Recent Developments/Updates
  • 2.7 Nitto Denko
    • 2.7.1 Nitto Denko Details
    • 2.7.2 Nitto Denko Major Business
    • 2.7.3 Nitto Denko Transdermal Patch Product and Services
    • 2.7.4 Nitto Denko Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Nitto Denko Recent Developments/Updates
  • 2.8 Grünenthal
    • 2.8.1 Grünenthal Details
    • 2.8.2 Grünenthal Major Business
    • 2.8.3 Grünenthal Transdermal Patch Product and Services
    • 2.8.4 Grünenthal Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Grünenthal Recent Developments/Updates
  • 2.9 IBSA Group
    • 2.9.1 IBSA Group Details
    • 2.9.2 IBSA Group Major Business
    • 2.9.3 IBSA Group Transdermal Patch Product and Services
    • 2.9.4 IBSA Group Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 IBSA Group Recent Developments/Updates
  • 2.10 GSK
    • 2.10.1 GSK Details
    • 2.10.2 GSK Major Business
    • 2.10.3 GSK Transdermal Patch Product and Services
    • 2.10.4 GSK Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 GSK Recent Developments/Updates
  • 2.11 Luye Pharma Group
    • 2.11.1 Luye Pharma Group Details
    • 2.11.2 Luye Pharma Group Major Business
    • 2.11.3 Luye Pharma Group Transdermal Patch Product and Services
    • 2.11.4 Luye Pharma Group Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Luye Pharma Group Recent Developments/Updates
  • 2.12 Pfizer
    • 2.12.1 Pfizer Details
    • 2.12.2 Pfizer Major Business
    • 2.12.3 Pfizer Transdermal Patch Product and Services
    • 2.12.4 Pfizer Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Pfizer Recent Developments/Updates
  • 2.13 Chattem
    • 2.13.1 Chattem Details
    • 2.13.2 Chattem Major Business
    • 2.13.3 Chattem Transdermal Patch Product and Services
    • 2.13.4 Chattem Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Chattem Recent Developments/Updates
  • 2.14 Dr Reddy’s Laboratories
    • 2.14.1 Dr Reddy’s Laboratories Details
    • 2.14.2 Dr Reddy’s Laboratories Major Business
    • 2.14.3 Dr Reddy’s Laboratories Transdermal Patch Product and Services
    • 2.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
  • 2.15 Bayer
    • 2.15.1 Bayer Details
    • 2.15.2 Bayer Major Business
    • 2.15.3 Bayer Transdermal Patch Product and Services
    • 2.15.4 Bayer Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Bayer Recent Developments/Updates
  • 2.16 Mundipharma
    • 2.16.1 Mundipharma Details
    • 2.16.2 Mundipharma Major Business
    • 2.16.3 Mundipharma Transdermal Patch Product and Services
    • 2.16.4 Mundipharma Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Mundipharma Recent Developments/Updates
  • 2.17 Endo International
    • 2.17.1 Endo International Details
    • 2.17.2 Endo International Major Business
    • 2.17.3 Endo International Transdermal Patch Product and Services
    • 2.17.4 Endo International Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Endo International Recent Developments/Updates
  • 2.18 Beijing Tide Pharmaceutical
    • 2.18.1 Beijing Tide Pharmaceutical Details
    • 2.18.2 Beijing Tide Pharmaceutical Major Business
    • 2.18.3 Beijing Tide Pharmaceutical Transdermal Patch Product and Services
    • 2.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Transdermal Patch by Manufacturer

  • 3.1 Global Transdermal Patch Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Transdermal Patch Revenue by Manufacturer (2020-2025)
  • 3.3 Global Transdermal Patch Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Transdermal Patch by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Transdermal Patch Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Transdermal Patch Manufacturer Market Share in 2024
  • 3.5 Transdermal Patch Market: Overall Company Footprint Analysis
    • 3.5.1 Transdermal Patch Market: Region Footprint
    • 3.5.2 Transdermal Patch Market: Company Product Type Footprint
    • 3.5.3 Transdermal Patch Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Transdermal Patch Market Size by Region
    • 4.1.1 Global Transdermal Patch Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Transdermal Patch Consumption Value by Region (2020-2031)
    • 4.1.3 Global Transdermal Patch Average Price by Region (2020-2031)
  • 4.2 North America Transdermal Patch Consumption Value (2020-2031)
  • 4.3 Europe Transdermal Patch Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Transdermal Patch Consumption Value (2020-2031)
  • 4.5 South America Transdermal Patch Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Transdermal Patch Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Transdermal Patch Sales Quantity by Type (2020-2031)
  • 5.2 Global Transdermal Patch Consumption Value by Type (2020-2031)
  • 5.3 Global Transdermal Patch Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Transdermal Patch Sales Quantity by Application (2020-2031)
  • 6.2 Global Transdermal Patch Consumption Value by Application (2020-2031)
  • 6.3 Global Transdermal Patch Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Transdermal Patch Sales Quantity by Type (2020-2031)
  • 7.2 North America Transdermal Patch Sales Quantity by Application (2020-2031)
  • 7.3 North America Transdermal Patch Market Size by Country
    • 7.3.1 North America Transdermal Patch Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Transdermal Patch Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Transdermal Patch Sales Quantity by Type (2020-2031)
  • 8.2 Europe Transdermal Patch Sales Quantity by Application (2020-2031)
  • 8.3 Europe Transdermal Patch Market Size by Country
    • 8.3.1 Europe Transdermal Patch Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Transdermal Patch Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Transdermal Patch Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Transdermal Patch Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Transdermal Patch Market Size by Region
    • 9.3.1 Asia-Pacific Transdermal Patch Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Transdermal Patch Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Transdermal Patch Sales Quantity by Type (2020-2031)
  • 10.2 South America Transdermal Patch Sales Quantity by Application (2020-2031)
  • 10.3 South America Transdermal Patch Market Size by Country
    • 10.3.1 South America Transdermal Patch Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Transdermal Patch Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Transdermal Patch Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Transdermal Patch Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Transdermal Patch Market Size by Country
    • 11.3.1 Middle East & Africa Transdermal Patch Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Transdermal Patch Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Transdermal Patch Market Drivers
  • 12.2 Transdermal Patch Market Restraints
  • 12.3 Transdermal Patch Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Transdermal Patch and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Transdermal Patch
  • 13.3 Transdermal Patch Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Transdermal Patch Typical Distributors
  • 14.3 Transdermal Patch Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Transdermal Patch market size was valued at US$ 7498 million in 2024 and is forecast to a readjusted size of USD 9524 million by 2031 with a CAGR of 3.5% during review period.
    Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
    Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
    Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
    Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
    This report is a detailed and comprehensive analysis for global Transdermal Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Transdermal Patch market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
    Global Transdermal Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
    Global Transdermal Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
    Global Transdermal Patch market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (USD/Pc), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Transdermal Patch
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Transdermal Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Transdermal Patch market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Methyl Salicylate-based Patch
    Rivastigmine Transdermal Patch
    Fentanyl Transdermal Patch
    Lidocaine Patch
    Diclofenac Patch
    Nicotine Transdermal Patch
    Others
    Market segment by Application
    Rx Channel
    OTC Channel
    Major players covered
    Hisamitsu Pharmaceutical
    Johnson & Johnson
    Novartis
    UCB Pharma
    Mylan
    Teva Pharmaceutical
    Nitto Denko
    Grünenthal
    IBSA Group
    GSK
    Luye Pharma Group
    Pfizer
    Chattem
    Dr Reddy’s Laboratories
    Bayer
    Mundipharma
    Endo International
    Beijing Tide Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Transdermal Patch product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Transdermal Patch, with price, sales quantity, revenue, and global market share of Transdermal Patch from 2020 to 2025.
    Chapter 3, the Transdermal Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Transdermal Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Transdermal Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Patch.
    Chapter 14 and 15, to describe Transdermal Patch sales channel, distributors, customers, research findings and conclusion.

    Buy now